Cannabinoids for sleep disorders: Weeding through the evidence

Jennifer H. Walsh, Peter R. Eastwood

Research output: Contribution to journalEditorial

2 Citations (Scopus)


Sleep disorders are common and include obstructive sleep apnoea (OSA), insomnia, parasomnias, movement disorders and neurological disorders such as narcolepsy. Consequences of untreated sleep disorders include cardiovascular disease, metabolic dysfunction, cognitive impairment and depression. The financial burden of sleep disorders is also significant with the total annual cost of undiagnosed OSA in the US alone estimated to be in excess of US$149b in 2015 [1]. It is estimated that US$100b per year would be saved if every adult with OSA in the US were diagnosed and treated.
Original languageEnglish
Article number101363
Number of pages3
JournalSleep Medicine Reviews
Publication statusPublished - Oct 2020
Externally publishedYes


  • apnoea
  • insomnia
  • parasomnias
  • Sleep disorders
  • Cannabinoids


Dive into the research topics of 'Cannabinoids for sleep disorders: Weeding through the evidence'. Together they form a unique fingerprint.

Cite this